This clinical trial aims to evaluate the efficacy of cisplatin alone versus cisplatin combined with gemcitabine in patients with carcinoma of unknown primary and a favorable prognosis. The study is sponsored by Gustave Roussy, Cancer Campus, Grand Paris, and is currently recruiting participants.